IBM Clinical Development has a lot of potential
September 12, 2021

IBM Clinical Development has a lot of potential

Anonymous | TrustRadius Reviewer
Score 9 out of 10
Vetted Review
Verified User

Overall Satisfaction with IBM Clinical Development (ICD)

ICD is currently being piloted by certain project teams in Development. The hope is that ICD can help us better organize and visualize clinical trial information.
  • Provides detailed data on-demand
  • Allows rapid study design
  • Provides standardization across all clinical trial elements
  • Some modules are expensive.
  • Reporting could be more user friendly (steep learning curve).
  • Training should utilize more (simple) examples.
  • Time savings
  • Consistency
ICD is a powerful tool which can really improve clinical trial efficiency, quality, and consistency. However the user interface does require significant training and is often not intuitive. User training could be improved, and simpler examples.
We have had no problems with user support response times or availability.

Do you think Merative Clinical Development delivers good value for the price?

Not sure

Are you happy with Merative Clinical Development's feature set?


Did Merative Clinical Development live up to sales and marketing promises?


Did implementation of Merative Clinical Development go as expected?


Would you buy Merative Clinical Development again?


ICD is a good tool for companies currently utilizing multiple software platforms to create and monitor clinical trial information. Due to the price, it is best suited for large pharmaceutical manufacturers with active pipelines and high R&D spend. ICD's value is more limited to smaller, more focused companies.